Summary
An open, prospective trial was conducted to compare the efficacy of a bacterial extract (OM-85 BV) [‘Broncho-Vaxom’] vs conventional management in the prevention of chronic, recurrent respiratory diseases in children. 61 children aged between 1 and 11 years who had presented three or more respiratory tract infections in the last 6 months were enrolled. 30 children (mean age 4.1 ± 2.7 years) received one capsule a day of Broncho-Vaxom, 10 days a month, for 3 consecutive months, and 31 (mean age 3.8 ± 2.0 years) received no Broncho-Vaxom and served as a control group. During the 6-month follow-up period, patients treated with Broncho-Vaxom showed a significant reduction in the average number of infections (2.25 ± 0.58 vs 4.68 ± 0.94, p < 0.05); they were ill a lesser number of days (11.8 ± 3.67 vs 28.06 ± 6.72, p < 0.05), were exposed to fewer antibacterial treatments (1.1 ± 0.76 vs 2.52 ± 0.85, p < 0.05), required less additional treatment with conventional drugs (2.17 ± 0.59 vs 4.39 ± 0.88, p < 0.05), and spent fewer days under treatment (14.27 ± 7.27 vs 30 ± 6.49, p < 0.05). In conclusion, Broncho-Vaxom appears to be a practical, safe option for lowering the incidence of respiratory tract infections in susceptible children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Haskins R, Kotch J. Day care and illness: evidence, costs, and public policy. Pediatrics 1986; Suppl. 2: 951–82
Bell DM, Gleiber DW, Mercer AA, et al. Illness associated with child day care: a study of incidence and cost. Am J Public Health 1989; 79: 479–84
Bale JR. Creation of a research program to determine the etiology and epidemiology of acute respiratory tract infection among children in developing countries. Rev Infect Dis 1990; 12 Suppl. 8: S861–6
Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991; 87: 129–33
Erwick-Roberts J, Burchinal MR, Collier AM, et al. Otitis media in early childhood and cognitive, academic and classroom performance of the school-aged child. Pediatrics 1989; 83: 477–85
Loda FA, Glezen WP, Clyde WA. Respiratory disease in around day care. Pediatrics 1972; 49: 428–37
Dingle JH, Badger GF, Jordan WJ. Illness in the home. Cleveland, Ohio: Press of Case Western Reserve University, 1964
Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Rev Infect Dis 1990; 12 Suppl. 8: S870–88
Wald ER, Guerra N, Byers C. Frequency and severity of infections in day care: three-year follow-up. J Pediatr 1991; 118: 509–14
Hurwitz ES, Gunn WJ, Pinsky PF, et al. Risk of respiratory illness associated with day-care attendance: a nationwide study. Pediatrics 1991; 87: 62–9
Fleming DW, Cochi SL, Hightower AW, et al. Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics 1987; 79: 55–60
Anderson LJ, Parker RA, Strikas RA, et al. Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics 1988; 82: 300–8
Soderstrom M, Hovelius B, Prellner K. Respiratory tract infections in children with recurrent episodes as preschoolers. Acta Paediatr Scand 1991; 80: 688–95
De Baets F, Kint J, Pauwels R, et al. IgG subclass deficiency in children with recurrent bronchitis. Eur J Pediatr 1992; 151: 274–8
Mauël J. Stimulation of immuno-protective mechanisms by OM-85 BV. Respiration 1994; 61 Suppl. 1: 8–15
Mauël J, Van Pham T, Kreis B, et al. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int J Immunopharmacol 1989; 11: 637–45
Emmerich B, Emslander HP, Pachmann K, et al. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration 1990; 57: 90–9
Lusuardi M, Capelli A, Carli S, et al. Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest 1993; 103: 1783–91
Paupe J. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 1991; 58: 150–4
Collet J-P, Ducruet T, Kramer MS, et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr Infect Dis J 1993; 12: 648–52
Grove AK, Bergemann R, Keller R. Preventive treatment of chronic bronchitis: a cost-effectiveness analysis for an immunoactive bacterial extract in Switzerland. Br J Med Econ 1996; 10: 1–14
Aymard M, Chomel JJ, Allard JP, et al. Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virology status of children attending day-car centers. Respiration 1994; 61 Suppl. 1: 24–31
Puigdollers JM, Serna GR, Hernández del Rey I, et al. Immunoglobulin production in man stimulated by orally administered bacterial lysate. Respiration 1980; 40: 142–9
Fitzgerald L. Exercise and the immune system. Immunol Today 1988; 9: 337–9
Jemmott JB, McClelland DC. Secretory Ig A as a measure of resistance to infectious disease: comments on Stone, Cox, Valdimarsdottir and Neale. Behav Med 1989; 15: 63–71
Rossen RD, Butler WT, Waldman RH, et al. The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washing from men infected with influenza virus. JAMA 1970; 211: 1157–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gutiérrez-Tarango, M.D., Berber, A. Efficacy of a Bacterial Extract (OM-85 BV) in Preventing Recurrent Respiratory Tract Infections in Susceptible Children. Clin. Drug Invest. 13, 76–84 (1997). https://doi.org/10.2165/00044011-199713020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-199713020-00003